The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status

Daniel J Canter; Steve Nicholson; Nick Watkin; Emma Hall; Curtis Pettaway; InPACT Executive Committee

doi:10.1016/j.euf.2019.05.010

The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status

Eur Urol Focus. 2019 Sep;5(5):706-709. doi: 10.1016/j.euf.2019.05.010. Epub 2019 Jun 1.

Authors

Daniel J Canter¹, Steve Nicholson², Nick Watkin³, Emma Hall², Curtis Pettaway⁴; InPACT Executive Committee

Affiliations

¹ Department of Urology, Ochsner Clinic, New Orleans, LA, USA.
² Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
³ Department of Urology, St. George's Teaching Hospital, London, UK.
⁴ Department of Urology, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA. Electronic address: [email protected].

PMID: 31160252
DOI: 10.1016/j.euf.2019.05.010

Abstract

The historic international penile cancer trial InPACT is now open and accruing patients in the UK and USA. The trial is geared to answer important questions for patients with evidence of inguinal lymph node disease at presentation. This clinical trial update provides an overview of the study and progress to date.

Publication types

Clinical Trial Protocol

MeSH terms

Carcinoma, Squamous Cell / secondary
Carcinoma, Squamous Cell / therapy*
Humans
Male
Neoplasm Staging
Penile Neoplasms / pathology
Penile Neoplasms / therapy*
Prospective Studies
Randomized Controlled Trials as Topic / methods*

Grants and funding

16050/CRUK_/Cancer Research UK/United Kingdom